Status:
UNKNOWN
Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder
Lead Sponsor:
Adana Numune Training and Research Hospital
Collaborating Sponsors:
Kocaeli University
Akdeniz University
Conditions:
Overactive Bladder
Eligibility:
FEMALE
18-70 years
Phase:
PHASE4
Brief Summary
Null hypothesis of the trial is that there is no difference between solifenacin and oxybutynin with respect to efficacy, side effects, patient satisfaction and quality of life measures in patients wit...
Detailed Description
In this two-month follow-up study, the patients with overactive bladder will be randomly assigned into two groups (solifenacin or oxybutynin in their usual doses) and will be assessed with respect to ...
Eligibility Criteria
Inclusion
- Women between 18-70 years of age, diagnosed to have overactive bladder (presence of at least two of the following three main criteria: urgency, urge incontinence, frequency and nocturia)
Exclusion
- Presence of stress urinary incontinence, patients who are still using a drug for overactive bladder, pregnant women, women in postpartum period (women on lactation), patients who have closed angle glaucoma, patients with chronic constipation, having allergy to the ingredients of the drugs, patients having the contraindicated conditions listed in the printed instructions of the drugs.
- \-
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2012
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT01423838
Start Date
September 1 2011
End Date
September 1 2012
Last Update
August 26 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Turkish Republic Ministry of Health Adana Numune Training and Research Hospital
Adana, Turkey (Türkiye), 01150